However, a recent assessment of splenic NK cell populations from panobinostat-treated tumor-bearing mice showed increased surface expression of the activating receptors NKG2D and DNAM-1, while the expression of the inhibitory receptors NKG2A and Ly49I/C was decreased (130), albeit further mechanistic insights are still to be exploited. This evidence concerns the gene KLRC1 and neoplasm.